Yagyu T, Monden T, Baba M, Tamaki Y, Takeda T, Kobayashi T, Shimano T, Tsuji Y, Matsushita H, Osawa H
Second Department of Surgery, Osaka University Medical School.
Jpn J Cancer Res. 1993 Jan;84(1):75-82. doi: 10.1111/j.1349-7006.1993.tb02787.x.
A human monoclonal antibody, YJ-37 (IgM) was generated through the fusion of human B lymphoblastoid cell line HO-323 with the regional lymph node lymphocytes from a colonic cancer patient who was treated with a local immunotherapy. This antibody was purified and conjugated with biotin, after which direct immunohistochemical staining was performed. The results revealed that YJ-37 selectively reacted with colonic cancer (7/19), gastric cancer (3/6), endometrial cancer (1/2) and colonic adenoma (7/13), but not with normal epithelia. Membrane immunofluorescence and FACS analysis also showed that YJ-37 bound to tumor cell surfaces. Furthermore, the chemical structure of the antigen defined by YJ-37 was analyzed by means of thin-layer chromatography immunostaining and ELISA. The results indicated that YJ-37 reacted with sialylated lacto-series carbohydrate chains, which have been reported to accumulate in cancer cells.
通过将人B淋巴母细胞系HO-323与一名接受局部免疫治疗的结肠癌患者的区域淋巴结淋巴细胞融合,产生了一种人单克隆抗体YJ-37(IgM)。该抗体经纯化后与生物素偶联,随后进行直接免疫组织化学染色。结果显示,YJ-37与结肠癌(7/19)、胃癌(3/6)、子宫内膜癌(1/2)和结肠腺瘤(7/13)有选择性反应,但与正常上皮无反应。膜免疫荧光和流式细胞术分析也表明YJ-37与肿瘤细胞表面结合。此外,通过薄层色谱免疫染色和酶联免疫吸附测定法分析了YJ-37所定义抗原的化学结构。结果表明,YJ-37与唾液酸化乳糖系列碳水化合物链发生反应,据报道这些碳水化合物链在癌细胞中积累。